REFERENCES
-
1
Favaloro E J.
Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008.
Semin Thromb Hemost.
2008;
34
693-696
-
2
Favaloro E J.
A tribute to Eberhard F. Mammen, M.D. (1930–2008).
Semin Thromb Hemost.
2008;
34(8)
703-707
-
3
Favaloro E J.
Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009.
Semin Thromb Hemost.
2009;
35
1-2
-
4
Favaloro E J.
Editorial. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article.
Semin Thromb Hemost.
2009;
35
587-590
-
5
Favaloro E J.
Editorial. 2009 Eberhard F. Mammen Young Investigator Award Winners.
Semin Thromb Hemost.
2010;
36(6)
469-470
-
6
Harenberg J, Wehling M.
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Semin Thromb Hemost.
2008;
34(1)
39-57
-
7
Prechel M, Walenga J M.
The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
Semin Thromb Hemost.
2008;
34(1)
86-96
-
8
Fareed J, Hoppensteadt D A, Fareed D et al..
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Semin Thromb Hemost.
2008;
34(1)
58-73
-
9
Asherson R A, Cervera R, Merrill J T, Erkan D.
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Semin Thromb Hemost.
2008;
34(3)
256-266
-
10
Jurk K, Kehrel B E.
Platelets: physiology and biochemistry.
Semin Thromb Hemost.
2005;
31(4)
381-392
-
11
Wong R C, Favaloro E J.
Clinical features, diagnosis, and management of the antiphospholipid syndrome.
Semin Thromb Hemost.
2008;
34(3)
295-304
-
12
Enjeti A K, Lincz L F, Seldon M.
Detection and measurement of microparticles: an evolving research tool for vascular biology.
Semin Thromb Hemost.
2007;
33(8)
771-779
-
13
Tincani A, Bazzani C, Zingarelli S, Lojacono A.
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.
Semin Thromb Hemost.
2008;
34(3)
267-273
-
14
Viiala N O, Larsen S R, Rasko J E.
Gene therapy for hemophilia: clinical trials and technical tribulations.
Semin Thromb Hemost.
2009;
35(1)
81-92
-
15
Pierangeli S S, Chen P P, Raschi E et al..
Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
Semin Thromb Hemost.
2008;
34(3)
236-250
-
16
Tripodi A, van den Besselaar A.
Laboratory monitoring of anticoagulation: where do we stand?.
Semin Thromb Hemost.
2009;
35(1)
34-41
-
17
Sobieraj-Teague M, O'Donnell M, Eikelboom J.
New anticoagulants for atrial fibrillation.
Semin Thromb Hemost.
2009;
35(5)
515-524
-
18
Lippi G, Favaloro E J, Franchini M, Guidi G C.
Milestones and perspectives in coagulation and hemostasis.
Semin Thromb Hemost.
2009;
35(1)
9-22
-
19
Tiu R V, Mountantonakis S E, Dunbar A J, Schreiber Jr M J.
Tumor lysis syndrome.
Semin Thromb Hemost.
2007;
33(4)
397-407
-
20
Watson H G, Greaves M.
Can we predict bleeding?.
Semin Thromb Hemost.
2008;
34(1)
97-103
-
21
Hunt B J.
Pediatric antiphospholipid antibodies and antiphospholipid syndrome.
Semin Thromb Hemost.
2008;
34(3)
274-281
-
22
Laux V, Perzborn E, Kubitza D, Misselwitz F.
Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor.
Semin Thromb Hemost.
2007;
33(5)
515-523
-
23
Blum W, Porcu P.
Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
Semin Thromb Hemost.
2007;
33(4)
350-354
-
24
Boekholdt S M, Kramer M H.
Arterial thrombosis and the role of thrombophilia.
Semin Thromb Hemost.
2007;
33(6)
588-596
-
25
Franchini M, Franchi M, Bergamini V, Salvagno G L, Montagnana M, Lippi G.
A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
Semin Thromb Hemost.
2008;
34(1)
104-112
-
26
Levi M, Löwenberg E C.
Thrombocytopenia in critically ill patients.
Semin Thromb Hemost.
2008;
34(5)
417-424
-
27
Cohn D M, Roshani S, Middeldorp S.
Thrombophilia and venous thromboembolism: implications for testing.
Semin Thromb Hemost.
2007;
33(6)
573-581
-
28
Wada H, Usui M, Sakuragawa N.
Hemostatic abnormalities and liver diseases.
Semin Thromb Hemost.
2008;
34(8)
772-778
-
29
Jeske W P, Walenga J M, Hoppensteadt D A et al..
Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
Semin Thromb Hemost.
2008;
34(1)
74-85
-
30
Ho V T, Linden E, Revta C, Richardson P G.
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.
Semin Thromb Hemost.
2007;
33(4)
373-388
-
31
Galli M.
Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Semin Thromb Hemost.
2008;
34(4)
329-334
-
32
Favaloro E J.
Clinical utility of the PFA-100.
Semin Thromb Hemost.
2008;
34(8)
709-733
-
33
Bernardi E, Pesavento R, Prandoni P.
Upper extremity deep venous thrombosis.
Semin Thromb Hemost.
2006;
32(7)
729-736
-
34
Selleng K, Selleng S, Greinacher A.
Heparin-induced thrombocytopenia in intensive care patients.
Semin Thromb Hemost.
2008;
34(5)
425-438
-
35
Harenberg J.
Development of new anticoagulants: present and future.
Semin Thromb Hemost.
2008;
34(8)
779-793
-
36
Mariani G, Bernardi F.
Factor VII deficiency.
Semin Thromb Hemost.
2009;
35(4)
400-406
-
37
Gisondi P, Girolomoni G.
Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
Semin Thromb Hemost.
2009;
35(3)
313-324
-
38
Esmon C T.
Inflammation and the activated protein C anticoagulant pathway.
Semin Thromb Hemost.
2006;
32(Suppl 1)
49-60
-
39
Schaffner F, Ruf W.
Tissue factor and protease-activated receptor signaling in cancer.
Semin Thromb Hemost.
2008;
34(2)
147-153
-
40
Roberts H R, Hoffman M, Monroe D M.
A cell-based model of thrombin generation.
Semin Thromb Hemost.
2006;
32(Suppl 1)
32-38
-
41
Harris E N, Pierangeli S S.
Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?.
Semin Thromb Hemost.
2008;
34(3)
219-226
-
42
Wong R C, Favaloro E J.
Antiphospholipid antibodies and the antiphospholipid syndrome. I: pathogenesis, clinical features, diagnosis, and management. Preface.
Semin Thromb Hemost.
2008;
34(3)
213-218
-
43
Douma R A, Kamphuisen P W.
Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile?.
Semin Thromb Hemost.
2007;
33(8)
821-828
-
44
Lippi G, Franchini M, Montagnana M, Guidi G C.
Coagulation testing in pediatric patients: the young are not just miniature adults.
Semin Thromb Hemost.
2007;
33(8)
816-820
-
45
McGlasson D L, Fritsma G A.
Whole blood platelet aggregometry and platelet function testing.
Semin Thromb Hemost.
2009;
35(2)
168-180
-
46
Zakarija A, Bennett C.
Drug-induced thrombotic microangiopathy.
Semin Thromb Hemost.
2005;
31(6)
681-690
-
47
Espinosa G, Bucciarelli S, Asherson R A, Cervera R.
Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
Semin Thromb Hemost.
2008;
34(3)
290-294
-
48
Miesbach W.
Neurologic symptoms as a feature of the antiphospholipid syndrome.
Semin Thromb Hemost.
2008;
34(3)
286-289
-
49
Girolami B, Girolami A.
Heparin-induced thrombocytopenia: a review.
Semin Thromb Hemost.
2006;
32(8)
803-809
-
50
Althaus K, Greinacher A.
MYH9-related platelet disorders.
Semin Thromb Hemost.
2009;
35(2)
189-203
-
51
Favaloro E J, Wong R C.
Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions.
Semin Thromb Hemost.
2008;
34(4)
389-410
-
52
Savi P, Herbert J M.
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Semin Thromb Hemost.
2005;
31(2)
174-183
-
53
Dempfle C E, Borggrefe M.
Point of care coagulation tests in critically ill patients.
Semin Thromb Hemost.
2008;
34(5)
445-450
-
54
Kenet G, Strauss T, Kaplinsky C, Paret G.
Hemostasis and thrombosis in critically ill children.
Semin Thromb Hemost.
2008;
34(5)
451-458
-
55
Harrison P, Mumford A.
Screening tests of platelet function: update on their appropriate uses for diagnostic testing.
Semin Thromb Hemost.
2009;
35(2)
150-157
-
56
Favaloro E J.
Measuring the quality of journals and journal articles: the impact factor tells but a portion of the story.
Semin Thromb Hemost.
2008;
34(1)
7-25
-
57
Favaloro E J, Wong R C.
Dedication: Professor Ronald A. Asherson, M.D. (Hon), F.R.C.P., M.D., F.A.C.P., F.C.P., F.A.C.R., Dip. O&G (Hon) [1934–2008].
Semin Thromb Hemost.
2008;
34(3)
211
Emmanuel J FavaloroPh.D. M.A.I.M.S.
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR)
Westmead Hospital, WSAHS, Westmead, NSW 2145, Australia
Email: emmanuel.favaloro@swahs.health.nsw.gov.au
